BOULDER, Colo., Nov. 9, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the following upcoming conferences. The public is welcome to participate in the conferences through webcasts on the Array BioPharma website: www.arraybiopharma.com.
http://photos.prnewswire.com/prnvar/20121029/LA02195LOGO
Event: Stifel 2015 Healthcare Conference Date: Tuesday, November 17, 2015 Time: 2:15 p.m. Eastern Standard Time Location: New York Palace Hotel, New York City Event: Jefferies 2015 Global Healthcare Conference Date: Thursday, November 19, 2015 Time: 3:20 p.m. Greenwich Mean Time Location: London, England
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162 / wholly-owned), encorafenib (LGX818 / wholly-owned) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com.
CONTACT: Tricia Haugeto Array BioPharma Inc. 303-386-1193 thaugeto@arraybiopharma.com
Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-stifel-2015-healthcare-and-jefferies-2015-global-healthcare-conferences-300175230.html
SOURCE Array BioPharma Inc.